Genomind Press

Standard Process Partners With Genomind® To Offer Mindful DNA – A Breakthrough In Personalized Wellness

PALMYRA, WI — June 21, 2018 — Standard Process and Genomind have announced a partnership to assist patients with personal wellness. Genomind is the developer of the new genetic test Mindful DNA® Professional, used to help guide lifestyle, diet and nutritional supplement decisions to improve the overall health and wellbeing of patients.

Mindful DNA provides evidence-based, personalized, actionable information, based on patients’ genetic results that helps them adjust their lifestyle, diet, habits and activities to improve their overall quality of life. It analyzes variations in 32 key genes in six domains of health: Cognition & Mental Acuity, Cardiometabolic, Gastrointestinal (GI) & Immune, Stress & Emotional Wellbeing, Inflammation and Sleep.

Testing with Mindful DNA is simple and quick. A DNA sample is collected by a cheek swab and the results are returned to the ordering clinician in 10 days or less. Healthcare practitioners can then use the Mindful DNA test results to create personalized wellness plans using Standard Process products.

“This is a very exciting step that allows us to provide practitioners and patients advanced insight into patient resiliency from stress and anxiety,” says John Troup, PhD, Standard Process Vice President of Clinical Science, Education & Innovation. “With the genetic results from Mindful DNA, we will be able to bridge the gap between mind and body, and provide more personalized nutritional support. This is a perfect fit for our commitment to being the preferred practitioner partner in the delivery of advanced nutrition therapy programs and expertise. We chose Genomind because they have conducted over 150,000 genetic tests for patients around the world and developed Mindful DNA based on their expertise in brain health and belief in the importance of the mind-body connection.”

“We know Standard Process as the visionary leader in whole food nutrient solutions,” says Dr. Jay Lombard, Genomind Co-founder and Chief Scientific Officer. “We are proud that Mindful DNA will now be able to help Standard Process healthcare practitioners and patients identify variations in gene networks that influence health and wellness.”

About Standard Process Inc.

Standard Process is a family-owned company dedicated to making high-quality and nutrient-dense therapeutic supplements for three generations. The company focuses on achieving wholistic health through nutrition. From its organic, regenerative farming practice to their Nutrition Innovation Center research facility, Standard Process is committed to clinical science that advances health and transforms lives. From soil to supplement, there is a direct relationship between the earth, food consumed and overall wellbeing.

Guided by the whole food philosophy of its founder, Dr. Royal Lee, Standard Process seeks to provide nutrients as found in nature, which Lee believed offered the highest natural potency and efficacy. Today Standard Process proudly carries on Dr. Lee’s legacy and regularly grows more than 80 percent of the raw plant ingredients found in its products on its certified organic farm in Palmyra, Wisconsin. Using state-of-the-art manufacturing processes to retain vital nutrients within each ingredient, Standard Process manufacturers its supplements in its certified organic manufacturing facility. Standard Process employs high quality control standards and follows the Food and Drug Administration’s good manufacturing practices.

About Genomind

Genomind® is a unique personalized medicine platform that brings innovation to healthcare around the world. Genomind, comprised of pioneering scientists and thought leaders in brain health and genetics, delivers actionable insights to clinicians, healthcare partners and individuals in order to improve the quality of human life. Learn more at

About Mindful DNA

Mindful DNA® Professional is a genetic test used by clinicians that helps guide lifestyle, diet and/or nutritional supplement decisions to improve the overall health and wellbeing of patients. It was created based on Genomind’s expertise in brain health and belief in the importance of the mind-body connection. The results report provides personalized, actionable information that helps patients adjust their lifestyle, habits and activities in order to improve their quality of life. The test analyzes 32 genes in six key areas, or domains, of health: Cognition & Mental Acuity, Cardiometabolic, GI & Immune, Stress & Emotional Wellbeing, Inflammation and Sleep. For each at-risk gene result, the test report specifies holistic steps patients can take in collaboration with their healthcare provider to achieve better health. Learn more at

"*" indicates required fields

This field is for validation purposes and should be left unchanged.